Which natural ingredients can be used to replace synthetic compounds in a toothpaste?
How does the human gut microbiome affect intestinal disorders?
Is gene G a suitable drug target for disease D?
Which biomolecular pathways relate to COPD severity?
Which bacteria contribute to periodontal disease related bacterial growth?
How does the gut microbiome influence the gut-brain axis?
Does selenium sulphide provide a long lasting treatment for dandruff?
Which microbial strains associate with body odour?
Can we influence the viability of bio-film forming strains of bacteria?
What is the safety profile of hydroquinone cream?
Which pathways effect psoriasis sufferers using drug treatments?
Which datasets should I integrate to understand the safety profile of Drug D?
What is the risk profile of drug D?
Which patients are likely to experience side-effects from checkpoint inhibitors?
Which human signalling pathways are affected by drug D?
Which patient groups are most affected by treatment T?
Which natural ingredients can be used to replace synthetic compounds in a toothpaste?
How does the human gut microbiome affect intestinal disorders?
Is gene G a suitable drug target for disease D?
Which biomolecular pathways relate to COPD severity?
Which bacteria contribute to periodontal disease related bacterial growth?
How does the gut microbiome influence the gut-brain axis?
Does selenium sulphide provide a long lasting treatment for dandruff?
Which microbial strains associate with body odour?
Can we influence the viability of bio-film forming strains of bacteria?
What is the safety profile of hydroquinone cream?
Which pathways effect psoriasis sufferers using drug treatments?
Which datasets should I integrate to understand the safety profile of Drug D?
What is the risk profile of drug D?
Which patients are likely to experience side-effects from checkpoint inhibitors?
Which human signalling pathways are affected by drug D?
Which patient groups are most affected by treatment T?
Organisations in food, agritech, personal care and healthcare are deploying our life sciences data management and knowledge discovery platform, the e[datascientist], to explore the connections between data entities from disparate public and proprietary datasets.
The platform applies knowledge graph, AI and unique valuation technology to reveal entities of interest beyond the tacit knowledge of a scientist or team of scientists to spark novel insights and drive innovation. The platform enables further exploration, analysis and collaboration around those new insights to drastically increase the efficiency of the innovation cycle, reducing product time to market.
The outcome for our customers is: more efficient R&D teams bringing more innovative, differentiated and efficacious products to market in less time.
Microbiome data far exceeds genomic data in complexity and scale, presenting an unprecedented challenge for researchers, innovators and businesses.
The e[datascientist] addresses the large-scale challenges associated with microbiome data management and knowledge discovery, to enable scientists in enterprise organisations to generate credible hypotheses around host-microbiome interactions and understand the systemic impact of multi-omics data in relation to the microbiome.
Using the e[datascientist], companies can
generate novel microbiome insights to enable development of new and enhanced products which address key health and environmental challenges.
Capture, curate and federate experimental data and metadata
Enrich and prioritise concepts/entities to measure relevance
Explore a graph-based data structure to visualise relationships
Map contextualised data into a common knowledge framework
Apply world-class integrated workflows to scale up analysis
Copyright © 2020 Eagle Genomics.
